Disli, S. Y. Et Al. 2024. Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.2 , 68-73.

Disli, S. Y., Ayas, E., Disli, A. K., & Ozdemir, F., (2024). Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.2, 68-73.

Disli, Safak Et Al. "Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.2, 68-73, 2024

Disli, Safak Y. Et Al. "Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.2, pp.68-73, 2024

Disli, S. Y. Et Al. (2024) . "Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.2, pp.68-73.

@article{article, author={Safak Yildirim Disli Et Al. }, title={Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2024, pages={68-73} }